Vorinostat Terminated Phase 1 / 2 Trials for Peripheral T-Cell Non-Hodgkin's Lymphoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs